Quality & Compliance

How a new collaboration looks to improve analytical testing for mRNA products.

Counterfeit deterrents are not yet available in some regions. We speak with Advanco CEO Alf Goebel to find out why.

What does sustainability look like at Cytiva?

Following on from deaths attributed to contaminated medicines, here’s how the US Pharmacopeia is promoting testing for DEG and EG.

Introducing the British Standards Institution’s new environmental initiative to minimize antimicrobial resistance caused by manufacturing operations.

Data is power when it comes to batch-quality prediction and obtaining the coveted perfect profile.

It’s December – time for The Medicine Maker to welcome you to 2023’s most innovative new technologies in drug development and manufacturing

The details and reactions behind a recent FDA investigation into the cancer-risk of CAR-T therapies

Why drug developers are turning to this technique for rapid detection of replication-competent viruses.

How do we encourage the development of new cell and gene therapies without compromising our ethics?